David Driscoll to Nanoparticles
This is a "connection" page, showing publications David Driscoll has written about Nanoparticles.
Connection Strength
1.685
-
Driscoll DF, Bistrian BR. Pharmaceutical Considerations and Metabolic Fate of Parenteral Lipid Nanoparticle Dosage Forms. J Pharm Sci. 2024 Aug; 113(8):2560-2564.
Score: 0.588
-
Driscoll DF. Lipid nanoparticle-based COVID-19 vaccines: Ensuring pharmaceutical stability, safety, and efficacy. Am J Health Syst Pharm. 2023 12 05; 80(24):1847-1849.
Score: 0.572
-
Driscoll DF. Lipid nanoparticle-based COVID-19 vaccines: Concerns about stability. Am J Health Syst Pharm. 2022 09 07; 79(18):1514-1515.
Score: 0.525